Evidence map›Paper›PMID 38740933›Full record

ArticleNature nanotechnology2024

Single-site iron-anchored amyloid hydrogels as catalytic platforms for alcohol detoxification.

Jiaqi Su, Pengjie Wang, Wei Zhou, Mohammad Peydayesh, Jiangtao Zhou, Tonghui Jin, Felix Donat, Cuiyuan Jin, Lu Xia, Kaiwen Wang and 4 more

Abstract read
In one paragraph

Article in Nature nanotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jiaqi Su *Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. jiaqi.su@hest.ethz.ch.ORCID http://orcid.org/0000-0003-2010-8388
Pengjie Wang *Department of Nutrition and Health, Beijing Higher Institution Engineering Research Center of Animal Products, China Agricultural University, Beijing, China.ORCID http://orcid.org/0000-0001-9975-6737
Wei ZhouDepartment of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
Mohammad PeydayeshDepartment of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-6265-3811
Jiangtao ZhouDepartment of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-4248-2207
Tonghui JinDepartment of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
Felix DonatInstitute of Energy and Process Engineering, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3940-9183
Cuiyuan JinInstitute of Translational Medicine, Zhejiang Shuren University, Zhejiang, China.
Lu XiaICFO-Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2726-5389
Kaiwen WangICFO-Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1046-4525
Fazheng RenDepartment of Nutrition and Health, Beijing Higher Institution Engineering Research Center of Animal Products, China Agricultural University, Beijing, China.ORCID http://orcid.org/0000-0001-6250-0754
Paul Van der MeerenParticle and Interfacial Technology Group, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0001-5405-4256
F Pelayo García de ArquerICFO-Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2422-6234
Raffaele MezzengaDepartment of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. raffaele.mezzenga@hest.ethz.ch.ORCID http://orcid.org/0000-0002-5739-2610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Constructing effective antidotes to reduce global health impacts induced by alcohol prevalence is a challenging topic. Despite the positive effects observed with intravenous applications of natural enzyme complexes, their insufficient activities and complicated usage often result in the accumulation of toxic acetaldehyde, which raises important clinical concerns, highlighting the pressing need for stable oral strategies. Here we present an effective solution for alcohol detoxification by employing a biomimetic-nanozyme amyloid hydrogel as an orally administered catalytic platform. We exploit amyloid fibrils derived from β-lactoglobulin, a readily accessible milk protein that is rich in coordinable nitrogen atoms, as a nanocarrier to stabilize atomically dispersed iron (ferrous-dominated). By emulating the coordination structure of the horseradish peroxidase enzyme, the single-site iron nanozyme demonstrates the capability to selectively catalyse alcohol oxidation into acetic acid, as opposed to the more toxic acetaldehyde. Administering the gelatinous nanozyme to mice suffering from alcohol intoxication significantly reduced their blood-alcohol levels (decreased by 55.8% 300 min post-alcohol intake) without causing additional acetaldehyde build-up. Our hydrogel further demonstrates a protective effect on the liver, while simultaneously mitigating intestinal damage and dysbiosis associated with chronic alcohol consumption, introducing a promising strategy in effective alcohol detoxification.

Indexed as

AmyloidEthanolHydrogelsIronAlcoholic IntoxicationAnimalsCatalysisInactivation, MetabolicLactoglobulinsLiverMaleMiceAmyloidEthanolHydrogelsIronLactoglobulins

Identifiers

PMID38740933
PMCPMC11329373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.